ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,420.26
-0.22%
Dow Jones
40,003.59
0.34%
Gold vs US Dollar
2,413.935
0.00%
Brent Oil
83.76
0.00%
Bitcoin
66,860.10
-0.33%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Avadel Pharmaceuticals PLC (AVDL)

  7. Avadel Pharmaceuticals PLC (AVDL) News

Avadel Pharmaceuticals (AVDL)

Avadel Pharmaceuticals PLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:AVDL
DateTimeSourceHeadlineSymbolCompany
17/05/202421:18Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202421:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202421:06Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202414:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202413:29IH Market NewsU.S. Futures Slightly Dip Amid Corporate Earnings and Quiet Economic Calendar, Oil Prices FallNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202412:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/05/202412:00GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports First Quarter 2024 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
01/05/202413:00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 8NASDAQ:AVDLAvadel Pharmaceuticals PLC
01/04/202413:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the 23rd Annual Needham Healthcare ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
05/03/202413:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at Upcoming Investor ConferencesNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202420:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202420:37GlobeNewswire Inc.Avadel Pharmaceuticals Issues Statement On Patent LitigationNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202411:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202411:30GlobeNewswire Inc.Avadel Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202411:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202411:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
04/03/202411:24Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
26/02/202413:00GlobeNewswire Inc.Avadel Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full Year 2023 Financial Results on March 4NASDAQ:AVDLAvadel Pharmaceuticals PLC
14/02/202412:11Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
13/02/202422:54Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
13/02/202421:39Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
13/02/202414:40Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:AVDLAvadel Pharmaceuticals PLC
12/02/202413:20Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:AVDLAvadel Pharmaceuticals PLC
07/02/202413:00GlobeNewswire Inc.Avadel Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:AVDLAvadel Pharmaceuticals PLC
16/01/202421:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/01/202412:20Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/01/202412:00GlobeNewswire Inc.Avadel Pharmaceuticals Announces Strong LUMRYZ Launch Performance and Provides Preliminary Fourth Quarter and Full Year 2023 Financial HighlightsNASDAQ:AVDLAvadel Pharmaceuticals PLC
29/12/202321:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
28/12/202319:54Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:AVDLAvadel Pharmaceuticals PLC
08/11/202314:25Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:AVDLAvadel Pharmaceuticals PLC
 Showing the most relevant articles for your search:NASDAQ:AVDL

Your Recent History

NASDAQ
BSCV
Invesco BulletShares 203...
BOV
R1JF34
Raymond James Financial
LSE
SCLP
Scancell
LSE
TY18
Citi Fun 25
LSE
0QM5
Emmi
NASDAQ
ACLID
COIN
SHIBAIUST
Shibai Token
EU
D085T
D085T
ASX
ANZWOU
LSE
BLP
Blue Planet Investment
LSE
3SNP
Granite 3s Nflx
BITMOT
889415
Prog Quinto Eur1m+0,6 Ot...
COIN
MRIIETH
Marshall Rogan Inu
ASX
CBALOR
BIT
3BID
Exchange Traded
TSXV
BYU
Bayswater Uranium Corporation
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved